Organometallics
Article
Preparation of [Mo2Cp{μ-κ1,η5:κ1,η1-(C5H4)PC(CO2Me)C-
(CO2Me)C(O)}(η6-HMes*)(CO){P(OMe)3}] (8). The procedure is
analogous to that described for 7, but using P(OMe)3 (6 μL, 0.051
mmol) and a reaction time of 20 min. After similar workup, compound
8 was isolated as a green microcrystalline solid (0.030 g, 70%). Anal.
Calcd for C39H54Mo2O9P2: C, 50.88; H, 5.91. Found: C, 50.73; H,
5.81. 1H NMR: δ 5.25, 5.05, 4.86, 4.59 (4 m, 4 × 1H, C5H4), 5.16 (s,
5H, Cp), 4.83 (s, br, 3H, C6H3), 3.69, 3.60 (2s, 2 × 3H, OMe), 3.48
(d, JHP = 11, 9H, POMe), 1.17 (s, 27H, tBu). 1H NMR (C6D6): δ 5.37
(s, 5H, Cp), 5.02, 4.87, 4.79, 4.58 (4 m, 4 × 1H, C5H4), 4.71 (s, br,
3H, C6H3), 3.66 (d, JHP = 11, 9H, POMe), 3.43, 3.42 (2s, 2 × 3H,
OCH3), 1.06 (s, 27H, tBu). 13C{1H} NMR: δ 278.4 [dd, JCP = 38, 11,
MoC(O)], 256.7 (dd, JCP = 42, JCP = 28, MoCO), 169.5, 169.3 (2s, 2
× CO2Me), 165.6 (d, JCP = 26, PCC), 159.2 (s, PCC), 112.2 [s,
br, C(C6H3)], 94.2 (s, Cp), 90.2 [d, JCP = 4, CH(C5H4)], 89.5 [d, JCP
= 12, C(C5H4)], 86.7 [d, JCP = 9, CH(C5H4)], 84.8 [s, CH(C5H4)],
82.7 [d, JCP = 18, CH(C5H4)], 72.0 [s, br, CH(C6H3)], 52.6, 51.8 (2s,
2 × OMe), 52.5 (d, JCP = 6, POMe), 35.1 [s, C(tBu)], 31.3 [s,
CH3(tBu)].
[d, JCP = 15, CH(C5H4)], 71.8 [s, CH(C6H3)], 51.5 (s, OMe), 35.3 [s,
C(tBu)], 31.3 [s, CH3(tBu)], 19.4, 18.9 [2s, CH3(Xyl)]. Spectroscopic
data for anti-9b: H NMR (400.13 MHz): δ 6.90, 6.84 [2d, JHH = 7,
1
2H, m-H(Xyl)], 6.78 [d, JHP = 7, 1H, PCH], 6.71 [t, JHH = 7, 1H, p-
H(Xyl)], 5.34, 5.01, 4.94, 4.78 (4 m, 4 × 1H, C5H4), 5.28 (s, 5H, Cp),
4.89 (d, JHP = 3, 3H, C6H3), 3.05 (s, 3H, OMe), 2.19, 1.94 (2s, 2 ×
3H, Me), 1.20 (s, 27H, tBu). 1H NMR (400.13 MHz, C6D6): δ 7.12−
7.05 [m, 2H, m-H(Xyl)], 6.90 [t, JHH = 7, 1H, p-H(Xyl)], 6.79 (d, JHP
= 7, PCH), 5.23 (s, 5H, Cp), 5.02, 4.70, 4.43, 4.36 (4 m, 4 × 1H,
C5H4), 4.58 (d, JHP = 4, 3H, C6H3), 3.07 (s, 3H, OMe), 2.72, 2.18 (2s,
t
2 × 3H, Me), 0.98 (s, 27H, Bu). 13C{1H} NMR (100.61 MHz): δ
251.7 (d, JCP = 23, MoCO), 242.8 (s, MoCO), 208.1 [s, br,
MoC(NXyl)], 168.6 (d, JCP = 25, PCC), 156.8 [s, br, C1(Xyl)],
154.6 (s, br, PCH), 128.6, 123.9 [2s, br, C2,6(Xyl)], 127.6, 127.3 [2s,
br, C3,5(Xyl)], 121.7 [s, C4(Xyl)], 110.0 [s, C(C6H3)], 93.9 (s, Cp),
91.9 [d, JCP = 8, C(C5H4)], 90.1 [d, JCP = 5, CH(C5H4)], 85.2 [d, JCP
= 9, CH(C5H4)], 84.4 [s, CH(C5H4)], 80.8 [d, JCP = 14, CH(C5H4)],
72.9 [s, CH(C6H3)], 51.3 (s, OMe), 34.8 [s, C(tBu)], 31.4 [s,
CH3(tBu)], 20.4, 19.0 [2s, CH3(Xyl)].
Preparation of [Mo2Cp{μ-κ1,η5:κ1,η1-(C5H4)PC(CO2Me)C-
(CO2Me)C(NXyl)}(η6-HMes*)(CO)2] (9a). Xylylisocyanide (185 μL
of a 0.25 M solution in petroleum ether, 0.046 mmol) was added to a
solution of compound 1 (0.030 g, 0.046 mmol) and DMAD (8 μL,
0.065 mmol) in toluene (2 mL), whereupon the mixture changed
instantaneously from red to brown. The solvent was then removed
under vacuum, and the residue was chromatographed at 253 K.
Elution with dichloromethane gave a gray-purple fraction, yielding,
after removal of the solvent under vacuum, compound 9a as a brown
microcrystalline solid (0.038 g, 89%). Anal. Calcd for
C45H54O6Mo2NP: C, 58.26; H, 5.87; N, 1.51. Found: C, 58.16; H,
5.82; N, 1.34. 1H NMR: δ 6.93, 6.84 [2d, JHH = 7, 2 × 1H, m-H(Xyl)],
6.74 [t, JHH = 7, 1H, p-H(Xyl)], 5.20 (s, 5H, Cp), 5.16, 5.09, 4.73, 4.28
(4 m, 4 × 1H, C5H4), 4.97 (s, br, 3H, C6H3), 3.65 (s, 3H, OMe), 3.30
(s, br, 3H, OMe), 2.13, 1.88 (2s, 2 × 3H, Me), 1.18 (s, 27H, tBu). 1H
NMR (C6D6): δ 7.12−7.05 [m, 2H, m-H(Xyl)], 6.93 [t, JHH = 7, 1H,
p-H(Xyl)], 5.00 (s, 5H, Cp), 4.98 (s, br, 3H, C6H3), 4.89, 4.77, 4.74,
4.25 (4 m, 4 × 1H, C5H4), 3.77 (s, 3H, OMe), 3.20 (s, br, 3H, OMe),
2.36, 2.33 (2s, 2 × 3H, Me), 1.17 (s, 27H, tBu). 13C{1H} NMR (75.47
MHz): δ 253.5 (d, JCP = 26, MoCO), 240.9 (s, MoCO), 206.6 [s, br,
MoC(NXyl)], 168.9 (s, 2CO2Me), 168.4 (d, JCP = 22, PCC), 151.8
(s, PCC), 150.3 [s, br, C1(Xyl)], 127.7, 127.4 [2s, C3,5(Xyl)], 125.7,
125.0 [2s, br, C2,6(Xyl)], 122.1 [s, C4(Xyl)], 113.4 [s, br, C(C6H3)],
92.5 (s, Cp), 91.6 [d, JCP = 20, C(C5H4)], 88.4 [d, JCP = 4,
CH(C5H4)], 88.3, 83.5 [2s, CH(C5H4)], 82.7 [d, JCP = 17,
CH(C5H4)], 72.9 [s, CH(C6H3)], 52.8, 51.8 (2s, OMe), 35.5 [s,
C(tBu)], 31.3 [s, CH3(tBu)], 19.7, 18.6 [2s, CH3(Xyl)].
Preparation of [Mo2Cp{μ-κ1,η5:κ1,η1-(C5H4)PCHC{C(O)Me}-
C(NXyl)}(η6-HMes*)(CO)2] (9d). The preparative and purification
procedures are identical to those described for 9a, but using 3-butyn-2-
one instead (8 μL, 0.110 mmol). Elution with dichloromethane gave a
gray-brown band yielding compound 9d as a greenish-brown
microcrystalline solid (0.037 g, 94%). This compound was shown
(by NMR) to exist in solution as an equilibrium mixture of syn and
anti isomers, with the syn/anti ratio being 9:4 in C6D6 or CD2Cl2.
Anal. Calcd for C43H52O3Mo2NP: C, 60.49; H, 6.14; N, 1.64. Found:
1
C, 60.37; H, 6.01; N, 1.49. Spectroscopic data for syn-9d: H NMR
(400.13 MHz): δ 6.95, 6.88 [2d, JHH = 7, 2H, m-H(Xyl)], 6.79 [t, JHH
= 7, 1H, p-H(Xyl)], 6.50 (d, JHP = 8, 1H, PCH), 5.09 (s, 5H, Cp),
5.22, 5.15, 4.93, 4.45, (4 m, 4 × 1H, C5H4), 4.88 (d, JHP = 3, 3H,
C6H3), 2.09, 2.00 (2s, 2 × 3H, Me), 2.06 [s, br, 3H, C(O)Me], 1.16 (s,
t
1
27H, Bu). H NMR (300.13 MHz, C6D6): δ 7.18, 7.11 [2d, JHH = 7,
2H, m-H(Xyl)], 7.02 [t, JHH = 7, 1H, p-H(Xyl)], 6.59 (d, JHP = 8, 1H,
PCH), 4.86 (s, 5H, Cp), 4.77 (d, JHP = 4, 3H, C6H3), 4.75−4.66 (m, 3
× 1H, C5H4), 4.37 (m, 1H, C5H4), 2.41, 2.21 (2s, 2 × 3H, Me), 2.25
[s, 3H, C(O)Me], 1.06 (s, 27H, tBu). 13C{1H} NMR: δ 252.7 (d, JCP
=
30, MoCO), 241.2 (s, MoCO), 214.4 [s, C(O)Me], 203.4 [s, br,
MoC(NXyl)], 170.9 (d, JCP = 20, PCC), 152.5 [s, C1(Xyl)], 144.5
(s, br, PCH), 127.9, 127.5 [2s, C3,5(Xyl)], 126.0, 124.6 [2s, C2,6(Xyl)],
122.1 [s, C4(Xyl)], 111.8 [s, C(C6H3)], 91.9 (s, Cp), 92.6 [d, JCP = 18,
C(C5H4)], 89.0 [d, JCP = 8, CH(C5H4)], 88.3 [d, JCP = 4, CH(C5H4)],
83.6 [s, CH(C5H4)], 82.6 [d, JCP = 15, CH(C5H4)], 71.6 [s,
CH(C6H3)], 35.3 [s, C(tBu)], 31.3 [s, CH3(tBu)], 29.8 [s, br, C(O)
Me], 20.1, 18.8 [2s, Me(Xyl)]. Spectroscopic data for anti-9d: 1H NMR
(400.13 MHz): δ 6.95, 6.88 [2d, JHH = 7, 2H, m-H(Xyl)], 6.81 [t, JHH
= 7, 1H, p-H(Xyl)], 6.59 (d, JHP = 8, 1H, PCH), 5.10 (s, 5H, Cp),
5.07, 5.02, 4.99, 4.70, (4 m, 4 × 1H, C5H4), 4.86 (d, JHP = 4, 3H,
C6H3), 2.25, 1.96 (2s, 2 × 3H, Me), 2.02 [s, br, 3H, C(O)Me], 1.20 (s,
Preparation of [Mo2Cp{μ-κ1,η5:κ1,η1-(C5H4)PCHC(CO2Me)C-
(NXyl)}(η6-HMes*)(CO)2] (9b). The preparative and purification
procedures are identical to those described for 9a, but using methyl
propiolate instead (8 μL, 0.089 mmol). Elution with dichloromethane
gave a gray-brown band yielding compound 9b as a greenish-brown
microcrystalline solid (0.037 g, 92%). This compound was shown (by
NMR) to exist in solution as an equilibrium mixture of syn and anti
isomers, with the syn/anti ratio being 7:2 in C6D6 and 7:3 in CD2Cl2.
Anal. Calcd for C43H52O4Mo2NP: C, 59.38; H, 6.03; N, 1.61. Found:
t
1
27H, Bu). H NMR (400.13 MHz, C6D6): δ 7.18, 7.11 [2d, JHH = 7,
2H, m-H(Xyl)], 7.00 [t, JHH = 7, 1H, p-H(Xyl)], 6.68 (d, JHP = 8, 1H,
PCH), 5.03 (s, 5H, Cp), 4.75−4.66 (m, 3 × 1H, C5H4), 4.56 (d, JHP
4, 3H, C6H3), 4.45 (m, 1H, C5H4), 2.67, 2.14 (2s, 2 × 3H, Me), 2.25
[s, 3H, C(O)Me], 0.97 (s, 27H, tBu). 13C{1H} NMR: δ 253.8 (d, JCP
=
=
1
C, 59.24; H, 5.95; N, 1.37. Spectroscopic data for syn-9b: H NMR
21, MoCO), 241.6 (s, MoCO), 212.9 [s, C(O)Me], 207.1 [s, br,
MoC(NXyl)], 171.3 (d, JCP = 20, PCC), 152.9 [s, C1(Xyl)], 148.3
(s, br, PCH), 128.1, 127.7 [2s, C3,5(Xyl)], 125.8, 125.2 [2s, C2,6(Xyl)],
122.3 [s, C4(Xyl)], 110.0 [s, C(C6H3)], 92.6 (s, Cp), 90.0 [d, JCP = 4,
CH(C5H4)], 85.7 [d, JCP = 8, CH(C5H4)], 84.3 [s, CH(C5H4)], 80.7
[d, JCP = 15, CH(C5H4)], 72.7 [s, CH(C6H3)], 34.7 [s, C(tBu)], 31.5
[s, CH3(tBu)], 30.3 [s, br, C(O)Me], 20.5, 19.2 [2s, Me(Xyl)]. The
resonance for the C(C5H4) atom could not be identified in the
spectrum of the mixture of isomers.
(400.13 MHz): δ 6.90, 6.84 [2d, JHH = 7, 2H, m-H(Xyl)], 6.72 (d, JHP
= 7, 1H, PCH), 6.71 [t, JHH = 7, 1H, p-H(Xyl)], 5.22, 5.13, 4.89, 4.43
(4 m, 4 × 1H, C5H4), 5.21 (s, 5H, Cp), 4.89 (d, JHP = 3, 3H, C6H3),
3.17 (s, 3H, OMe), 2.13, 1.93 (2s, 2 × 3H, Me), 1.15 (s, 27H, tBu). 1H
NMR (400.13 MHz, C6D6): δ 7.12−7.05 [m, 2H, m-H(Xyl)], 6.90 [t,
JHH = 7, 1H, p-H(Xyl)], 6.86 [d, JHP = 7, PCH], 5.04 (s, 5H, Cp), 4.80
(d, JHP = 3, 3H, C6H3), 4.70 (m, 2H, C5H4), 4.61, 4.35 (2 m, 2 × 1H,
C5H4), 3.16 (s, 3H, OMe), 2.41, 2.37 (2s, 2 × 3H, Me), 1.07 (s, 27H,
tBu). 13C{1H} NMR (100.61 MHz): δ 253.5 (d, JCP = 28, MoCO),
241.1 (s, MoCO), 206.4 [s, br, MoC(NXyl)], 169.8 (d, JCP = 22,
PC=C), 158.4 [s, br, C1(Xyl)], 151.7 (s, br, PCH), 127.7, 127.4 [2s,
C3,5(Xyl)], 126.1, 125.1 [2s, br, C2,6(Xyl)], 121.7 [s, C4(Xyl)], 111.9
[s, br, C(C6H3)], 92.8 [d, JCP = 16, C(C5H4)], 92.1 (s, Cp), 88.5 [s,
CH(C5H4)], 88.4 [d, JCP = 4, CH(C5H4)], 83.4 [s, CH(C5H4)], 82.4
Preparation of [Mo2Cp{μ-κ1,η5:κ1,η3-(C5H4)PC(CO2Me)C-
(CO2Me)C(O)}(η6-HMes*)(CO)] (10). Method A. A solution of
compound 3a (0.032 g, 0.040 mmol) in toluene (5 mL) was irradiated
with visible−UV light at 288 K for 1 h to give a green solution. The
solvent was then removed under vacuum, and the residue was
chromatographed at 253 K. Elution with dichloromethane gave a green
2760
dx.doi.org/10.1021/om201048s | Organometallics 2012, 31, 2749−2763